Sunzen Biotech Bhd will engage with relevant government agencies in the next few months to increase the bird’s nest harvesting quota and boost exports to China, aiming to capture a larger market share and capitalise on the product’s growing demand in the republic.
Ecolite received approval from China’s customs authority in October last year to export its bottled bird’s nest to the country up to 2028. Sunzen, which changed its financial year-end from Dec 31 to June 30, reported a net profit of RM9.17 million and revenue of RM142.7 million for the 18 months ending June 30, 2024. Human health products comprised 80.45% of the revenue, while loan financing contributed 13.78%.
On April 8, Sunzen announced it will stop manufacturing and trading animal health products due to a challenging business environment. Moving forward, the company will focus on traditional Chinese medicine, herbal health foods and beverages, and loan financing via Finsource Credit.